標(biāo)題: Titlebook: Endocrine Disorders in Thalassemia; Physiopathological a Sebastiano Andò (Head of Endocrine Physiopathology Book 1995 Springer-Verlag Berli [打印本頁] 作者: Grant 時(shí)間: 2025-3-21 20:00
書目名稱Endocrine Disorders in Thalassemia影響因子(影響力)
書目名稱Endocrine Disorders in Thalassemia影響因子(影響力)學(xué)科排名
書目名稱Endocrine Disorders in Thalassemia網(wǎng)絡(luò)公開度
書目名稱Endocrine Disorders in Thalassemia網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Endocrine Disorders in Thalassemia被引頻次
書目名稱Endocrine Disorders in Thalassemia被引頻次學(xué)科排名
書目名稱Endocrine Disorders in Thalassemia年度引用
書目名稱Endocrine Disorders in Thalassemia年度引用學(xué)科排名
書目名稱Endocrine Disorders in Thalassemia讀者反饋
書目名稱Endocrine Disorders in Thalassemia讀者反饋學(xué)科排名
作者: Eeg332 時(shí)間: 2025-3-21 20:26
Short-term Follow-up Study of Thyroid Function in Polytransfused Thalassemic Patientsinvestigate the evolutive trend of thyroid function with elapsing of time and its relationship with chelation therapy. We have carried out a follow0up study of thyroid function in 45 polytransfused thalassemic patients, investigated in 1988 and again in 1992.作者: Jejune 時(shí)間: 2025-3-22 01:52
Spermatogenesis in Patients with β-Thalassaemia major and intermediahe assurance of greater longevity and with the prospect of future marriage. For these reasons, many new problems are emerging to challenge doctors who care for patients with thalassaemia. The purpose of this study was to evaluate the fertility potential of thalassaemic men who have achieved full sex作者: 擁護(hù) 時(shí)間: 2025-3-22 05:04
Long-term Follow-up of Hypothalamic-Pituitary Axis in Thalassaemic Patients with Secondary Amenorrhol data are available on secondary amenorrhoea (SA), which is a common sequela in transfusion-dependent thalassaemic patients, occurring in 15–25% of Italian thalassaemic patients [3, 13]. Similar figures are available for the United Kingdom [8].作者: babble 時(shí)間: 2025-3-22 09:59 作者: 報(bào)復(fù) 時(shí)間: 2025-3-22 13:14
Bone Mineral Content by Single- and Dual-Photon Absorptiometry in Thalassemic Patientsextramedullary hematopoiesis, hepatosplenomegaly, osteoporosis, cardiac failure, and increased susceptibility to infections contribute to the mortality and morbidity associated with the disease. Hypertransfusion therapy, although it has dramatically increased the duration and quality of life of thal作者: 報(bào)復(fù) 時(shí)間: 2025-3-22 21:02
Osteopenia in Thalassemic Patients with Primary and Secondary Amenorrheality of accurately measuring bone density at the level of the lumbar spine and femur has significantly improved the sensitivity of measurements in thalassemic patients with primary and secondary amenorrhea, using double X-ray absorptiometry (DXA), to investigate the incidence of osteopenia and its c作者: 真實(shí)的人 時(shí)間: 2025-3-22 22:24
Imaging, Ultrastructural Aspects, and Trace Elements in the Thalassemic Condrodystrophy1], According to anatomopathological standards, the group of bone diseases observed during growth are characterized by cartilaginous lesions due mainly to both premature and asymmetrical fusion of the metaphyseal cartilage, while those observed in adults are expressed by skeleteal lesions [2–4]. In 作者: 手術(shù)刀 時(shí)間: 2025-3-23 03:43 作者: 自傳 時(shí)間: 2025-3-23 07:57 作者: cultivated 時(shí)間: 2025-3-23 10:43
A Multicenter Study on Endocrine Disorders in Thalassemia — Introductionarea and spans through the Middle East, to India and East Asia. In 1988 the WHO reported that 240,000 children per year are born with a major hemoglobinopathy — 20% with thalassemias and 80% with the sickle cell syndrome. The total number of thalassemic patients transfused and followed up at Italian作者: 珊瑚 時(shí)間: 2025-3-23 14:19
Endocrine Pathology in Thalassemiareased absorption from the gastrointestinal tract, with deleterious effects on internal organs and tissues [2, 7–9]. With modern treatment and longer survival, endocrine dysfunction assumes greater importance [1, 3–5]. This study was carried out in an attempt to correlate such dysfunction with patho作者: 設(shè)施 時(shí)間: 2025-3-23 18:38
Endocrine Complications in Cyprian Thalassemic Patientsblood transfusions results in deposits in many organs including the endocrine glands, causing endocrine dysfunction. The incidence of endocrinopathies in thalassemics has been reported to be high by several investigators [2, 3]. The gland most sensitive to iron deposition is thought to be the pituit作者: Archipelago 時(shí)間: 2025-3-24 00:39
Growth in Homozygous β-Thalassemic Patientsriety of endocrine abnormalities frequently occur in such patients. A number of studies have shown that as thalassemic patients approach the age of puberty, a percentage develop growth retardation [1]. The growth failure of these patients has been attributed to hypothyroidism, delayed sexual maturat作者: 甜得發(fā)膩 時(shí)間: 2025-3-24 05:12
Relationship Between GH Response to Stimuli, Levels of IGF-1, and Final Height are still major problems. Growth failure is generally accepted as beginning at the age of 10, with a marked decline in the growth rate after the age of 12–14 years [1, 2]. A recent report shows that height impairment occurs before the age of 10 [3]. While it is possible that delayed puberty may be 作者: Ganglion 時(shí)間: 2025-3-24 08:30
Glucose Intolerance and Diabetes in Thalassaemia majorn a particular tissue exceeds the tissue or blood binding capacity of iron, and large quantities of free nontransferrin iron appear. This “free iron” is a catalyst of the production of oxygen species that damage cells and peroxidize membrane lipids, leading to cell destruction. The liver has a large作者: SOBER 時(shí)間: 2025-3-24 14:31
A Multicenter Study on Endocrine Disorders in Thalassemia — Introductionroach to endocrine complications in thalassemia as too sophisticated. For this reason, I am certain that all of us are grateful to the organizing comittee for having planned this International Mediterranean Conference and for giving us an opportunity to collect and share the experiences from differe作者: 細(xì)菌等 時(shí)間: 2025-3-24 18:55
Endocrine Complications in Cyprian Thalassemic Patientspendent diabetes mellitus (IDDM) after the age of 15 years. The frequency of hypoparathyroidism and hypothyroidism is also very low, so that in this report we will address the issues of growth failure and hypogonadism, which are more commonly observed.作者: 忘川河 時(shí)間: 2025-3-24 20:28
https://doi.org/10.1007/978-1-349-66019-3n a particular tissue exceeds the tissue or blood binding capacity of iron, and large quantities of free nontransferrin iron appear. This “free iron” is a catalyst of the production of oxygen species that damage cells and peroxidize membrane lipids, leading to cell destruction. The liver has a large作者: 鬧劇 時(shí)間: 2025-3-24 23:17 作者: 高調(diào) 時(shí)間: 2025-3-25 06:29 作者: 費(fèi)解 時(shí)間: 2025-3-25 08:42 作者: 彎曲的人 時(shí)間: 2025-3-25 13:35
https://doi.org/10.1007/978-1-4614-9025-8ulin-like growth factor I (IGF.) activity is markedly reduced [1–5]. Therefore, the cause of the growth defect is likely to be at the GH receptor or post-receptor level: in either case it would lead to impairment of GH-induced generation of IGF..作者: exquisite 時(shí)間: 2025-3-25 19:23 作者: Trochlea 時(shí)間: 2025-3-25 22:30 作者: 處理 時(shí)間: 2025-3-26 02:20 作者: Chronic 時(shí)間: 2025-3-26 07:28 作者: agitate 時(shí)間: 2025-3-26 09:37 作者: Expediency 時(shí)間: 2025-3-26 16:26
https://doi.org/10.1007/978-0-85729-929-1lity of accurately measuring bone density at the level of the lumbar spine and femur has significantly improved the sensitivity of measurements in thalassemic patients with primary and secondary amenorrhea, using double X-ray absorptiometry (DXA), to investigate the incidence of osteopenia and its c作者: 不利 時(shí)間: 2025-3-26 19:33
Remembering and Imagining Palestine1], According to anatomopathological standards, the group of bone diseases observed during growth are characterized by cartilaginous lesions due mainly to both premature and asymmetrical fusion of the metaphyseal cartilage, while those observed in adults are expressed by skeleteal lesions [2–4]. In 作者: 領(lǐng)先 時(shí)間: 2025-3-26 21:26
https://doi.org/10.1007/978-1-349-66019-3 (DFX) [1]. This optimal treatment appears to ensure good health in the long term, if DFX chelation begins in early childhood and is complied with, and if there is no evidence of viral hepatitis, then the patients can be expected to survive for an indefinite duration. Most of the complications of th作者: Dendritic-Cells 時(shí)間: 2025-3-27 04:04
https://doi.org/10.1007/978-3-658-11320-9rapy. Diabetes in thalassemic patients seems to be the consequence of several factors. The iron overload damages the islet cells and also seems to decrease the sensitivity to insulin, which is compensated by increased secretion of insulin. So the diabetes may be due to a combination of insulin defic作者: JAMB 時(shí)間: 2025-3-27 06:28 作者: PLIC 時(shí)間: 2025-3-27 12:41
https://doi.org/10.1007/978-3-030-19511-3reased absorption from the gastrointestinal tract, with deleterious effects on internal organs and tissues [2, 7–9]. With modern treatment and longer survival, endocrine dysfunction assumes greater importance [1, 3–5]. This study was carried out in an attempt to correlate such dysfunction with patho作者: 捏造 時(shí)間: 2025-3-27 16:12 作者: inscribe 時(shí)間: 2025-3-27 19:21 作者: occurrence 時(shí)間: 2025-3-27 22:09
The Reasons for Sending Remittance Home, are still major problems. Growth failure is generally accepted as beginning at the age of 10, with a marked decline in the growth rate after the age of 12–14 years [1, 2]. A recent report shows that height impairment occurs before the age of 10 [3]. While it is possible that delayed puberty may be 作者: 泥沼 時(shí)間: 2025-3-28 05:54
Sergiy Dubchak,Olexander BondarLife expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.作者: 諂媚于性 時(shí)間: 2025-3-28 07:31 作者: sebaceous-gland 時(shí)間: 2025-3-28 14:20
Spontaneous Growth Hormone (GH) Secretion and Results of Therapy with GH in Thalassemic PatientsLife expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.作者: 可互換 時(shí)間: 2025-3-28 17:04
Thalassemia and Endocrinopathies: Multicenter Study of 3092 PatientsData regarding the prevalence of endocrine dysfunction in patients with β-thalassaemia major are limited [1, 2], We report the results of a collaborative study of endocrine complications in a large series of patients with β-thalassemia major followed in pediatric and hematology departments throughout Italy.作者: 發(fā)牢騷 時(shí)間: 2025-3-28 22:03
978-88-470-2185-3Springer-Verlag Berlin Heidelberg 1995作者: Vulnerable 時(shí)間: 2025-3-29 00:27 作者: 范圍廣 時(shí)間: 2025-3-29 04:05 作者: 祖先 時(shí)間: 2025-3-29 08:33
Joanne Garde-Hansen,Hannah Gristl data are available on secondary amenorrhoea (SA), which is a common sequela in transfusion-dependent thalassaemic patients, occurring in 15–25% of Italian thalassaemic patients [3, 13]. Similar figures are available for the United Kingdom [8].作者: violate 時(shí)間: 2025-3-29 12:40
https://doi.org/10.1007/978-3-030-19511-3reased absorption from the gastrointestinal tract, with deleterious effects on internal organs and tissues [2, 7–9]. With modern treatment and longer survival, endocrine dysfunction assumes greater importance [1, 3–5]. This study was carried out in an attempt to correlate such dysfunction with pathologic findings in major endocrine organs.作者: 冷淡一切 時(shí)間: 2025-3-29 18:57
Plasma Growth Hormone-Binding Protein and Liver Receptor in Thalassemic Patientsulin-like growth factor I (IGF.) activity is markedly reduced [1–5]. Therefore, the cause of the growth defect is likely to be at the GH receptor or post-receptor level: in either case it would lead to impairment of GH-induced generation of IGF..作者: GROVE 時(shí)間: 2025-3-29 23:36 作者: 招待 時(shí)間: 2025-3-29 23:53 作者: Adrenaline 時(shí)間: 2025-3-30 07:07 作者: Forsake 時(shí)間: 2025-3-30 11:12
https://doi.org/10.1007/978-88-470-2183-9blood; diabetes; diabetes mellitus; endocrine gland; growth; growth factor; growth hormone; hormone; insulin作者: 思想流動(dòng) 時(shí)間: 2025-3-30 14:05 作者: 禮節(jié) 時(shí)間: 2025-3-30 16:38
pectancy, while several endocrine abnormalities have been described in children, adolescents, and young adults suffering from thalassemia major. .The practical objective of this book is to establish guidelines for the management of endocrine disorders underlying the various phases of thalassemic lif作者: Microaneurysm 時(shí)間: 2025-3-30 21:03 作者: REIGN 時(shí)間: 2025-3-31 04:26
https://doi.org/10.1057/9781137347909y bone, and the subsequent thinning of cortical bone, as well as metabolic and endocrine dysfunction secondary to hemochromatosis [2, 3]. Concurrent osteopenia results in frequent pathological fractures and premature epiphyseal fusion [4, 5].作者: 凹處 時(shí)間: 2025-3-31 05:08 作者: 壁畫 時(shí)間: 2025-3-31 11:16
Remembering and Imagining Palestiney to both premature and asymmetrical fusion of the metaphyseal cartilage, while those observed in adults are expressed by skeleteal lesions [2–4]. In this paper we evaluate the lesions involving both the distal metaphysis of the femur and the proximal metaphysis of the tibia in thalassemic children between 8 and 11 years of age.作者: 財(cái)主 時(shí)間: 2025-3-31 16:23
Spermatogenesis in Patients with β-Thalassaemia major and intermedia care for patients with thalassaemia. The purpose of this study was to evaluate the fertility potential of thalassaemic men who have achieved full sexual maturation, either spontaneously or on treatment with gonadotrophins.作者: 犬儒主義者 時(shí)間: 2025-3-31 18:33 作者: 羞辱 時(shí)間: 2025-3-31 23:22 作者: 猛然一拉 時(shí)間: 2025-4-1 04:36 作者: FAST 時(shí)間: 2025-4-1 08:13
https://doi.org/10.1007/978-3-319-74243-4assemic patients, invariably leads to chronic iron overload, despite chelation, resulting in cardiomyopathy, hepatic cirrhosis, hyperpigmentation and multiple endocrine abnormalities, the most common being hypogonadotrophic hypogonadism.
